Clinical Trial Update: Effect of BM-MSCs in DCD Kidney Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on the use of bone marrow-derived mesenchymal stem cells (BM-MSCs) in donation-after-cardiac-death kidney transplantation, covering Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Tubular Necrosis

Drugs mentioned

• BM-MSCs (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Kidney Transplantation, Acute Kidney Tubular Necrosis | Phase 1, Phase 2 | Status: UNKNOWN